Literature DB >> 34141166

A mini-review of the rodent models for alcoholic liver disease: shortcomings, application, and future prospects.

Shi-Xuan Liu1, Yan-Chao Du2, Tao Zeng1.   

Abstract

Rodents are the most common models in studies of alcoholic liver disease (ALD). Although several rodents ALD models have been established and multiple mechanisms have been elucidated based on them, these models have some non-negligible shortcomings, specifically only inducing early stage (mainly steatosis, slight to moderate steatohepatitis) but not the whole spectrum of human ALD. The resistance of rodents to advanced ALD has been suggested to be due to the physiological differences between rodents and human beings. Previous studies have reported significant interstrain differences in the susceptibility to ethanol-induced liver injury and in the manifestation of ALD (such as different alteration of lipid profiles). Therefore, it would be interesting to characterize the manifestation of ethanol-induced liver damage in various rodents, which may provide a recommendation to investigators of ALD. Furthermore, more severe ALD models need to be established for the study of serious ALD forms, which may be achieved by using genetic modified rodents.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  alcoholic liver disease; animal model; ethanol; rodents

Year:  2021        PMID: 34141166      PMCID: PMC8201549          DOI: 10.1093/toxres/tfab042

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  99 in total

Review 1.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 2.  Hepatocellular carcinoma in the setting of alcohol-related liver disease.

Authors:  Nathalie Ganne-Carrié; Pierre Nahon
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 3.  Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

Authors:  Bin Gao; Ming-Jiang Xu; Adeline Bertola; Hua Wang; Zhou Zhou; Suthat Liangpunsakul
Journal:  Gene Expr       Date:  2017-04-14

4.  Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity.

Authors:  Arthur I Cederbaum
Journal:  Dig Dis       Date:  2011-04-27       Impact factor: 2.404

5.  Tectoridin, an isoflavone glycoside from the flower of Pueraria lobata, prevents acute ethanol-induced liver steatosis in mice.

Authors:  Yu Xiong; Yuqing Yang; Jin Yang; Hongyan Chai; Ying Li; Jing Yang; Ziming Jia; Zhengrong Wang
Journal:  Toxicology       Date:  2010-07-15       Impact factor: 4.221

6.  Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines.

Authors:  Li-Li Huang; Jian-Bo Wan; Bin Wang; Cheng-Wei He; Huan Ma; Tian-Wang Li; Jing X Kang
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-03-07       Impact factor: 4.006

Review 7.  Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths.

Authors:  Nick Sheron
Journal:  J Hepatol       Date:  2015-11-16       Impact factor: 25.083

8.  Increased susceptibility to liver disease in relation to alcohol consumption in women.

Authors:  S Loft; K L Olesen; M Døssing
Journal:  Scand J Gastroenterol       Date:  1987-12       Impact factor: 2.423

9.  CYP2E1 potentiation of LPS and TNFα-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Genes Nutr       Date:  2009-10-02       Impact factor: 5.523

10.  Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.

Authors:  Isabelle Larosche; Amal Choumar; Bernard Fromenty; Philippe Lettéron; Adjé Abbey-Toby; Holly Van Remmen; Charles J Epstein; Arlan Richardson; Gérard Feldmann; Dominique Pessayre; Abdellah Mansouri
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-20       Impact factor: 4.219

View more
  1 in total

Review 1.  Advancements in the Alcohol-Associated Liver Disease Model.

Authors:  Lin Zhu; Hai-Di Li; Jie-Jie Xu; Juan-Juan Li; Miao Cheng; Xiao-Ming Meng; Cheng Huang; Jun Li
Journal:  Biomolecules       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.